Patient presents with muscle atrophy, characterized by decreased muscle mass and weakness.  Onset of muscle wasting was reported as [gradual/sudden] and attributed to [potential cause, e.g., disuse, aging, underlying medical condition].  The patient exhibits [localized/generalized] muscle atrophy affecting the [specific muscle groups, e.g., quadriceps, biceps, hand muscles].  Symptoms include reduced muscle strength, difficulty with [activities of daily living, e.g., walking, gripping, lifting], and visible reduction in muscle size compared to the contralateral side.  Differential diagnosis includes denervation atrophy, disuse atrophy, sarcopenia, cachexia, and steroid-induced myopathy.  Assessment includes physical examination, evaluation of muscle strength using Medical Research Council (MRC) scale, and review of relevant medical history including medications, nutritional status, and family history of neuromuscular disorders.  Diagnostic testing may include electromyography (EMG), nerve conduction studies (NCS), blood tests to assess creatinine kinase (CK) levels, and imaging studies such as MRI or CT scan to evaluate the extent of muscle loss and identify any underlying pathology.  Treatment plan focuses on addressing the underlying cause of muscle atrophy and may include physical therapy for muscle strengthening exercises, occupational therapy to improve functional abilities, nutritional counseling to optimize protein intake, and medication management for any contributing medical conditions.  Patient education on disease progression, management strategies, and prognosis is provided.  Follow-up appointments are scheduled to monitor progress and adjust treatment as needed.  ICD-10 code [appropriate ICD-10 code, e.g., M62.50 for muscle atrophy, unspecified] is assigned.